Urine neutrophil gelatinase-associated lipocalin (NGAL) was one of the first biomarkers to be validated for predicting short-term mortality in patients with advanced AKI [5] and recently became part of the indicators to decide early start of dialysis [6]. The gene discussed is LCN2; the disease is acute kidney injury.